Sanofi (SNYNF) Revenue (2009 - 2026)

Sanofi (SNYNF) has 18 years of Revenue data on file, last reported at $12.3 billion in Q1 2026.

• Quarterly Revenue rose 18.21% year-over-year to $12.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.4 billion (up 26.04% YoY) and the FY2025 annual result came in at $50.8 billion, up 15.68% from the prior year.
• Revenue climbed to $12.3 billion in Q1 2026 per SNYNF's latest filing, from -$10.0 billion in the prior quarter.
• The five-year high for Revenue was $46.3 billion in Q4 2023, with the low at -$10.0 billion in Q4 2025.
• Average Revenue over 5 years is $13.4 billion, with a median of $10.9 billion recorded in 2022.
• Year-over-year, Revenue jumped 323.51% in 2023 and plunged 245.37% in 2025.
• Sanofi's Revenue stood at $10.9 billion in 2022, then jumped by 323.51% to $46.3 billion in 2023, then tumbled by 85.16% to $6.9 billion in 2024, then sank by 245.37% to -$10.0 billion in 2025, then jumped by 223.1% to $12.3 billion in 2026.
• Business Quant data shows SNYNF's Revenue at $12.3 billion in Q1 2026, -$10.0 billion in Q4 2025, and $37.8 billion in Q3 2025.